Phytochemical Characterization of Hibiscus tiliaceus L. Leaves and Evaluation of Their Antisickling, Antioxidant, and Anti-Inflammatory Activities
Authors:
- Marguerite Borive AmaniMAMarguerite Borive Amani
- Michel FrederichMichel Frederich
- Olivia JansenOJOlivia Jansen
- Olivier BonnetOBOlivier Bonnet
- Allison LedouxALAllison Ledoux
- Patrick B. MemvangaPMPatrick B. Memvanga
- Salomon Batina AgasaSASalomon Batina Agasa
- Ange Mouithys-MickaladAMAnge Mouithys-Mickalad
- Roland Marini Djang’eing’aRDRoland Marini Djang’eing’a
Open Access
Abstract
Sickle cell disease (SCD) is a neglected tropical disease (NTD) associated with severe health consequences, including death. Hibiscus tiliaceus L., from the Malvaceae family, is used traditionally in Kisangani, Democratic Republic of the Congo (DRC), to alleviate symptoms of SCD. However, the specific phytochemicals responsible for the observed therapeutic effects remain unclear. This study aims to characterize the aqueous leaf extract of H. tiliaceus and assess its biological activity against sickle cell disease, including its antisickling, antioxidant, and anti-inflammatory effects. Using techniques such as TLC, HPLC-UV/DAD, LC-MS, and NMR, we identified kaempferol 3-O-rutinoside and rutin in the aqueous extract of H. tiliaceus leaves. Rutin exhibited potent antioxidant and anti-inflammatory activities, with IC50 values of 5 µg/mL and 2.5 µg/mL, respectively. Conversely, kaempferol 3-O-rutinoside demonstrated superior antisickling activity, normalizing sickled red blood cells with an IC50 < 12.5 µg/mL. Due to the pathophysiology of SCD, which involves the polymerization of red blood cells, which induces oxidative stress and an inflammatory response, this study suggests the importance of H. tiliaceus for the management of SCD. Additionally, the combined effect of molecules in H. tiliaceus will help in normalizing erythrocytes, inhibiting free radicals generated by early hemolysis, thus contributing to inflammatory processes reduction. This finding provides evidence and validates the traditional use of H. tiliaceus aqueous extract for the management of SCD.Keywords
Funding Information
- M.B.A.’s PhD scholarship and laboratory access
This publication has 55 references indexed in Scilit:
- A pharmacological and toxicological biochemical study of cardiovascular regulatory effects of hibiscus, corn silk, marjoram, and chamomileHeliyon, 2023
- The Influence of Environmental Conditions on Secondary Metabolites in Medicinal Plants: A Literature ReviewChemistry & Biodiversity, 2021
- Neutrophil extracellular trap regulators in sickle cell disease: Modulation of gene expression of PADI4, neutrophil elastase, and myeloperoxidase during vaso‐occlusive crisisResearch and Practice in Thrombosis and Haemostasis, 2020
- High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemiaAnnals of Hematology, 2020
- Sickling-preventive effects of rutin is associated with modulation of deoxygenated haemoglobin, 2,3-bisphosphoglycerate mutase, redox status and alteration of functional chemistry in sickle erythrocytesHeliyon, 2019
- Morphine, a potential inhibitor of myeloperoxidase activityBiochimica et Biophysica Acta (BBA) - General Subjects, 2018
- Sickle Cell Disease in Sub-Saharan AfricaHematology/Oncology Clinics of North America, 2016
- Clinical events and their relation to the tumor necrosis factor-alpha and interleukin-10 genotypes in Sickle-Cell-Anemia patientsHematology/Oncology and Stem Cell Therapy, 2016
- Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease managementAmerican Journal of Hematology, 2011
- Phytomedicines (medicines derived from plants) for sickle cell disease2003